-->

Ad Unit (Iklan) BIG

Investigation announced for Investors in shares of Talis Biomedical Corporation (NASDAQ: TLIS) over potential Wrongdoing | openPR.com - New Public Relations: Business, Economy, Finances, Banking & Insurance

Investigation announced for Investors in shares of Talis Biomedical Corporation (NASDAQ: TLIS) over potential Wrongdoing An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Talis Biomedical Corporation. Investors who purchased shares of Talis Biomedical Corporation (NASDAQ: TLIS) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or

Related Posts

Subscribe Our Newsletter